MAPT and Alzheimer disease: The diagnostic criteria for AD was established based on amyloidosis, tau pathology, and neurodegeneration derived from cerebrospinal fluid (CSF), positron emission tomography (PET), and magnetic resonance imaging (MRI) proposed by the National Institute of Aging-Alzheimer Association (5, 6).